drug

bacillus calmette-guerin

1 story · latest Nov 6, 2026

Follow bacillus calmette-guerin. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by AstraZeneca

Timeline

FDA approves durvalumab plus BCG for high-risk non-muscle invasive bladder cancer

Nov 6Regulatory decisionAstraZeneca durvalumab

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.